Search results
Results From The WOW.Com Content Network
OPKO Health (OPK) closed the most recent trading day at $3.22, moving -0.92% from the previous trading session.
OPKO Health (OPK) delivered earnings and revenue surprises of -100% and 3.02%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
OPKO Health's (OPK) second-quarter results benefit from continued strength in its Pharmaceuticals segment. OPKO Health (OPK) Stock Gains 2.1% Despite Q2 Earnings Miss Skip to main content
Image source: The Motley Fool. Opko Health (NASDAQ: OPK) Q3 2024 Earnings Call Nov 07, 2024, 4:30 p.m. ET. Contents: Prepared Remarks. Questions and Answers. Call ...
OPKO Health (OPK) third-quarter results benefit from higher Product revenues and RAYALDEE prescription growth.
OPKO Health (OPK) has been upgraded to a Zacks Rank 1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
OPKO Health (OPK) delivered earnings and revenue surprises of -250.00% and -3.31%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
OPKO Health, Inc. (NASDAQ:OPK) insiders have had a fantastic week as stock increased 5.1%, and they haven't stopped buying Simply Wall St October 30, 2022 at 5:04 AM